ANX007 is an antigen-binding fragment (Fab) antibody designed as a first-in-kind therapeutic to selectively inhibit C1q, the initiating molecule of the classical complement pathway and a key driver of ...

(left) Scientists have discovered a new CBCR binding PVB (pink) in a family of photoreceptors usually binding PCB (blue). (right) The new CBCR binding PVB (pink) can switch between two differently ...

Blinding diseases lead to permanent vision loss by damaging photoreceptor cells, which humans cannot naturally regenerate. While researchers are working on new methods to replace or regenerate these ...

Please provide your email address to receive an email when new articles are posted on . PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Reenie McCarthy of ...

Tiny biomimetic devices are indispensable for human-inspired robotics and computing applications. A paradigm change from sensing to perception, aided by machine learning and deep neural networks, ...